Skip to content

Evaluation of DCTclock™ as a Cognitive Assessment Aid

Evaluation of DCTclock™ as a Cognitive Assessment Aid

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03238001
Enrollment
450
Registered
2017-08-03
Start date
2017-07-11
Completion date
2017-11-21
Last updated
2018-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Function

Keywords

Cognitive assessment, Cognition, Clock Test

Brief summary

The overall objective of this study is to demonstrate the safety and effectiveness of DCTclock as an adjunctive tool for use by clinicians to evaluate cognitive function in adults aged 55-95.

Interventions

DEVICEDCTclock

DCTclock is a quick and non-invasive test that measures cognitive function based on a computerized algorithmic analysis of the entire drawing process and output of a well-established cognitive assessment called The Clock Drawing Test (CDT).

Sponsors

Digital Cognition Technologies
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Intervention model description

This study uses a paired design in which each subject undergoes blinded testing by separate testers administering DCTclock and a battery of reference standard tests to determine cognitive state.

Eligibility

Sex/Gender
ALL
Age
55 Years to 95 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women 55 to 95 years old.

Exclusion criteria

* Ineligible for written informed consent. * Physical impairment of the writing hand. * Impaired manual dexterity. * Impaired vision. * Under the influence of recreational drugs or alcohol at the time of the visit. * Current or recent participation in a clinical trial that includes the use of a drug or intervention to alter cognitive function. * Recent cognitive testing.

Design outcomes

Primary

MeasureTime frameDescription
Non-Inferiority of DCTclock Compared to Mini-Mental State Examination (MMSE)Visit 1 (day 1)The primary analysis will assess agreement between DCTclock and the Montreal Cognitive Assessment (MoCA) and compare it to the agreement between the MMSE and MoCA at visit 1.

Secondary

MeasureTime frameDescription
Quadratic Weighted Kappa on Primary EndpointsVisit 1 (day 1)Quadratic weighted Cohen's kappa with 95% CI between DCTclock and MoCA, as well as between MMSE and MoCA.
Percent Agreement on Primary EndpointsVisit 1 (day 1)Positive percent agreement, version A (treating the Indeterminate group as Unimpaired) and version B (removing the Indeterminate group from the analysis), and negative percent agreement version A and version B. These were calculated for the DCTclock/MoCA classification table as well as the MMSE/MoCA classification table. 95% CI were also calculated and compared between the two classification tables' calculations.
Regression Coefficients on Primary EndpointsVisit 1 (day 1)Linear and rank-linear regression coefficients (slope, intercept) and 95% CI for DCTclock regressed on MoCA as well as for the MMSE regressed on MoCA.
Correlation Coefficients on Primary EndpointsVisit 1 (day 1)Pearson and Spearman correlation coefficients between DCTclock and MoCA as well as between MMSE and MoCA.
Regression Coefficients on Secondary Endpoints (Test-retest Reliability)Visit 1 and visit 2, occurring 1-4 weeks apartDeming, linear, and rank-linear correlation coefficients (intercept, slope) were calculated for visit 1 regressed on visit 2 for both DCTclock and MMSE.
Correlation Coefficients on Secondary Endpoints (Test-retest Reliability)Visit 1 and visit 2, occurring 1-4 weeks apartPearson and Spearman correlation coefficients were calculated between visit 1 and visit 2 for DCTclock and MMSE, along with 95% CI.
Quadratic Weighted Kappa on Secondary Endpoints (Test-Retest Reliability)Visit 1 and visit 2, occurring 1-4 weeks apartQuadratic weighted Cohen's Kappa statistics were calculated for both DCTclock and MMSE test-retest data (visit 1 vs visit 2).
Percent Agreement on Secondary Endpoints (Test-retest Reliability)Visit 1 and visit 2, occurring 1-4 weeks apartPositive percent agreement version A (treating the Indeterminate group as Unimpaired) and version B (removing the Indeterminate group from the analysis), negative percent agreement version A and version B, indeterminate percent agreement, and unimpaired percent agreement.

Other

MeasureTime frameDescription
Construct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsVisit 1 (day 1)The goal of this analysis is to assess the construct validity of DCTclock. Specifically, the goal is to compare scores from the administration of DCTclock to the visit 1 administration of a battery of neuropsychological tests, to characterize the psychometric properties of DCTclock, and to compare those properties to the properties of MMSE.
Incidence of Serious Device-related Adverse Events [Safety]Visit 1 and visit 2, occuring 1-4 weeks apartIncidence of serious device-related adverse events.

Countries

United States

Participant flow

Recruitment details

Participants were enrolled at one site in the US.

Pre-assignment details

450 participants were enrolled. 14 did not meet screening criteria.

Participants by arm

ArmCount
All Participants
All participants enrolled in the study.
450
Total450

Withdrawals & dropouts

PeriodReasonFG000
Visit 1 (Primary Endpoint Cohort)Protocol Violation2
Visit 1 (Primary Endpoint Cohort)Unanalyzable test result2
Visit 2 (Secondary Endpoint Cohort)Lost to Follow-up16
Visit 2 (Secondary Endpoint Cohort)Met exclusion criteria at visit 23
Visit 2 (Secondary Endpoint Cohort)Protocol Violation4
Visit 2 (Secondary Endpoint Cohort)Study completion1
Visit 2 (Secondary Endpoint Cohort)Unanalyzable test result2
Visit 2 (Secondary Endpoint Cohort)Withdrawal by Subject3

Baseline characteristics

CharacteristicAll Participants
Age, Continuous68.94 years
STANDARD_DEVIATION 8.78
Ethnicity (NIH/OMB)
Hispanic or Latino
38 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
405 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
7 Participants
Handedness
Ambidextrous
13 Participants
Handedness
Left handed
34 Participants
Handedness
Other or unknown
7 Participants
Handedness
Right handed
396 Participants
Highest education level attained
College Degree +
148 Participants
Highest education level attained
High school
106 Participants
Highest education level attained
High School and some college
141 Participants
Highest education level attained
Less than high school
45 Participants
Highest education level attained
Unknown
10 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
6 Participants
Race (NIH/OMB)
Black or African American
105 Participants
Race (NIH/OMB)
More than one race
4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
6 Participants
Race (NIH/OMB)
White
329 Participants
Sex/Gender, Customized
Female
333 Participants
Sex/Gender, Customized
Male
114 Participants
Sex/Gender, Customized
Unknown or Other
3 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 436
other
Total, other adverse events
0 / 436
serious
Total, serious adverse events
1 / 436

Outcome results

Primary

Non-Inferiority of DCTclock Compared to Mini-Mental State Examination (MMSE)

The primary analysis will assess agreement between DCTclock and the Montreal Cognitive Assessment (MoCA) and compare it to the agreement between the MMSE and MoCA at visit 1.

Time frame: Visit 1 (day 1)

Population: The Evaluable Population includes all qualified participants undergoing cognitive testing with DCTclock, MMSE, and MoCA who completed visit 1.

ArmMeasureValue (NUMBER)
Primary Endpoint (Evaluable) PopulationNon-Inferiority of DCTclock Compared to Mini-Mental State Examination (MMSE)-0.035 Difference in Quadratic Weighted Kappas
Comparison: A two-one-sided tests approach was taken, where, prior to analysis, it was determined that a delta (equivalence margin) of 0.20 would be considered a significant difference between the DCTclock/MoCA kappa and the MMSE/MoCA kappa. The reasoning behind this determination can be found in the study's statistical analysis plan.90% CI: [-0.12, 0.05]
Secondary

Correlation Coefficients on Primary Endpoints

Pearson and Spearman correlation coefficients between DCTclock and MoCA as well as between MMSE and MoCA.

Time frame: Visit 1 (day 1)

ArmMeasureGroupValue (NUMBER)
Primary Endpoint (Evaluable) PopulationCorrelation Coefficients on Primary EndpointsPearson0.53 Correlation Coefficients
Primary Endpoint (Evaluable) PopulationCorrelation Coefficients on Primary EndpointsSpearman0.50 Correlation Coefficients
MMSECorrelation Coefficients on Primary EndpointsPearson0.59 Correlation Coefficients
MMSECorrelation Coefficients on Primary EndpointsSpearman0.55 Correlation Coefficients
Secondary

Correlation Coefficients on Secondary Endpoints (Test-retest Reliability)

Pearson and Spearman correlation coefficients were calculated between visit 1 and visit 2 for DCTclock and MMSE, along with 95% CI.

Time frame: Visit 1 and visit 2, occurring 1-4 weeks apart

ArmMeasureGroupValue (NUMBER)
Primary Endpoint (Evaluable) PopulationCorrelation Coefficients on Secondary Endpoints (Test-retest Reliability)Pearson0.70 Correlation Coefficients
Primary Endpoint (Evaluable) PopulationCorrelation Coefficients on Secondary Endpoints (Test-retest Reliability)Spearman0.67 Correlation Coefficients
MMSECorrelation Coefficients on Secondary Endpoints (Test-retest Reliability)Pearson0.67 Correlation Coefficients
MMSECorrelation Coefficients on Secondary Endpoints (Test-retest Reliability)Spearman0.56 Correlation Coefficients
Secondary

Percent Agreement on Primary Endpoints

Positive percent agreement, version A (treating the Indeterminate group as Unimpaired) and version B (removing the Indeterminate group from the analysis), and negative percent agreement version A and version B. These were calculated for the DCTclock/MoCA classification table as well as the MMSE/MoCA classification table. 95% CI were also calculated and compared between the two classification tables' calculations.

Time frame: Visit 1 (day 1)

Population: Version A treats the Indeterminate group as Unimpaired, while version B removes the Indeterminate group from the analysis. Thus, the analysis population for version B is smaller than the overall analysis population.

ArmMeasureGroupValue (NUMBER)
Primary Endpoint (Evaluable) PopulationPercent Agreement on Primary EndpointsPositive - Version A0.64 Percent Agreement
Primary Endpoint (Evaluable) PopulationPercent Agreement on Primary EndpointsPositive - Version B0.78 Percent Agreement
Primary Endpoint (Evaluable) PopulationPercent Agreement on Primary EndpointsNegative - Version A0.74 Percent Agreement
Primary Endpoint (Evaluable) PopulationPercent Agreement on Primary EndpointsNegative - Version B0.73 Percent Agreement
MMSEPercent Agreement on Primary EndpointsNegative - Version B0.88 Percent Agreement
MMSEPercent Agreement on Primary EndpointsPositive - Version A0.56 Percent Agreement
MMSEPercent Agreement on Primary EndpointsNegative - Version A0.83 Percent Agreement
MMSEPercent Agreement on Primary EndpointsPositive - Version B0.69 Percent Agreement
Secondary

Percent Agreement on Secondary Endpoints (Test-retest Reliability)

Positive percent agreement version A (treating the Indeterminate group as Unimpaired) and version B (removing the Indeterminate group from the analysis), negative percent agreement version A and version B, indeterminate percent agreement, and unimpaired percent agreement.

Time frame: Visit 1 and visit 2, occurring 1-4 weeks apart

Population: Version A treats the Indeterminate group as Unimpaired, while version B removes the Indeterminate group from the analysis. Thus, the analysis population for version B is smaller than the overall analysis population.

ArmMeasureGroupValue (NUMBER)
Primary Endpoint (Evaluable) PopulationPercent Agreement on Secondary Endpoints (Test-retest Reliability)Positive - Version A0.73 Percent Agreement
Primary Endpoint (Evaluable) PopulationPercent Agreement on Secondary Endpoints (Test-retest Reliability)Positive - Version B0.85 Percent Agreement
Primary Endpoint (Evaluable) PopulationPercent Agreement on Secondary Endpoints (Test-retest Reliability)Negative - Version A0.76 Percent Agreement
Primary Endpoint (Evaluable) PopulationPercent Agreement on Secondary Endpoints (Test-retest Reliability)Negative - Version B0.81 Percent Agreement
Primary Endpoint (Evaluable) PopulationPercent Agreement on Secondary Endpoints (Test-retest Reliability)Indeterminate0.21 Percent Agreement
Primary Endpoint (Evaluable) PopulationPercent Agreement on Secondary Endpoints (Test-retest Reliability)Unimpaired0.61 Percent Agreement
MMSEPercent Agreement on Secondary Endpoints (Test-retest Reliability)Indeterminate0.27 Percent Agreement
MMSEPercent Agreement on Secondary Endpoints (Test-retest Reliability)Positive - Version A0.74 Percent Agreement
MMSEPercent Agreement on Secondary Endpoints (Test-retest Reliability)Negative - Version B0.78 Percent Agreement
MMSEPercent Agreement on Secondary Endpoints (Test-retest Reliability)Positive - Version B0.84 Percent Agreement
MMSEPercent Agreement on Secondary Endpoints (Test-retest Reliability)Unimpaired0.63 Percent Agreement
MMSEPercent Agreement on Secondary Endpoints (Test-retest Reliability)Negative - Version A0.80 Percent Agreement
Secondary

Quadratic Weighted Kappa on Primary Endpoints

Quadratic weighted Cohen's kappa with 95% CI between DCTclock and MoCA, as well as between MMSE and MoCA.

Time frame: Visit 1 (day 1)

ArmMeasureValue (NUMBER)
Primary Endpoint (Evaluable) PopulationQuadratic Weighted Kappa on Primary Endpoints0.40 Quadratic Weighted Kappa
MMSEQuadratic Weighted Kappa on Primary Endpoints0.44 Quadratic Weighted Kappa
Secondary

Quadratic Weighted Kappa on Secondary Endpoints (Test-Retest Reliability)

Quadratic weighted Cohen's Kappa statistics were calculated for both DCTclock and MMSE test-retest data (visit 1 vs visit 2).

Time frame: Visit 1 and visit 2, occurring 1-4 weeks apart

ArmMeasureValue (NUMBER)
Primary Endpoint (Evaluable) PopulationQuadratic Weighted Kappa on Secondary Endpoints (Test-Retest Reliability)0.53 Quadratic Weighted Cohen's Kappa
MMSEQuadratic Weighted Kappa on Secondary Endpoints (Test-Retest Reliability)0.48 Quadratic Weighted Cohen's Kappa
Secondary

Regression Coefficients on Primary Endpoints

Linear and rank-linear regression coefficients (slope, intercept) and 95% CI for DCTclock regressed on MoCA as well as for the MMSE regressed on MoCA.

Time frame: Visit 1 (day 1)

ArmMeasureGroupValue (NUMBER)
Primary Endpoint (Evaluable) PopulationRegression Coefficients on Primary EndpointsLinear - Intercept19.35 Regression Coefficients
Primary Endpoint (Evaluable) PopulationRegression Coefficients on Primary EndpointsLinear - Slope0.07 Regression Coefficients
Primary Endpoint (Evaluable) PopulationRegression Coefficients on Primary EndpointsRank-Linear - Intercept107.75 Regression Coefficients
Primary Endpoint (Evaluable) PopulationRegression Coefficients on Primary EndpointsRank-Linear - Slope0.50 Regression Coefficients
MMSERegression Coefficients on Primary EndpointsRank-Linear - Slope0.55 Regression Coefficients
MMSERegression Coefficients on Primary EndpointsLinear - Intercept-5.03 Regression Coefficients
MMSERegression Coefficients on Primary EndpointsRank-Linear - Intercept96.45 Regression Coefficients
MMSERegression Coefficients on Primary EndpointsLinear - Slope1.03 Regression Coefficients
Secondary

Regression Coefficients on Secondary Endpoints (Test-retest Reliability)

Deming, linear, and rank-linear correlation coefficients (intercept, slope) were calculated for visit 1 regressed on visit 2 for both DCTclock and MMSE.

Time frame: Visit 1 and visit 2, occurring 1-4 weeks apart

ArmMeasureGroupValue (NUMBER)
Primary Endpoint (Evaluable) PopulationRegression Coefficients on Secondary Endpoints (Test-retest Reliability)Deming - Intercept8.77 Regression Coefficients
Primary Endpoint (Evaluable) PopulationRegression Coefficients on Secondary Endpoints (Test-retest Reliability)Deming - Slope0.93 Regression Coefficients
Primary Endpoint (Evaluable) PopulationRegression Coefficients on Secondary Endpoints (Test-retest Reliability)Linear - Intercept25.03 Regression Coefficients
Primary Endpoint (Evaluable) PopulationRegression Coefficients on Secondary Endpoints (Test-retest Reliability)Linear - Slope0.66 Regression Coefficients
Primary Endpoint (Evaluable) PopulationRegression Coefficients on Secondary Endpoints (Test-retest Reliability)Rank-Linear - Intercept66.48 Regression Coefficients
Primary Endpoint (Evaluable) PopulationRegression Coefficients on Secondary Endpoints (Test-retest Reliability)Rank-Linear - Slope0.67 Regression Coefficients
MMSERegression Coefficients on Secondary Endpoints (Test-retest Reliability)Rank-Linear - Intercept91.16 Regression Coefficients
MMSERegression Coefficients on Secondary Endpoints (Test-retest Reliability)Deming - Intercept2.96 Regression Coefficients
MMSERegression Coefficients on Secondary Endpoints (Test-retest Reliability)Linear - Slope0.62 Regression Coefficients
MMSERegression Coefficients on Secondary Endpoints (Test-retest Reliability)Deming - Slope0.91 Regression Coefficients
MMSERegression Coefficients on Secondary Endpoints (Test-retest Reliability)Rank-Linear - Slope0.55 Regression Coefficients
MMSERegression Coefficients on Secondary Endpoints (Test-retest Reliability)Linear - Intercept10.88 Regression Coefficients
Other Pre-specified

Construct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological Assessments

The goal of this analysis is to assess the construct validity of DCTclock. Specifically, the goal is to compare scores from the administration of DCTclock to the visit 1 administration of a battery of neuropsychological tests, to characterize the psychometric properties of DCTclock, and to compare those properties to the properties of MMSE.

Time frame: Visit 1 (day 1)

Population: Includes all qualified participants who completed testing at visit 1 and had evaluable data for each test analyzed. Roughly half of the population was administered the full neuropsychological battery. The remainder completed a partial battery (see protocol for details).

ArmMeasureGroupValue (NUMBER)
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsBenton Judgment of Line Orientation0.34 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsWAIS-IV Digit Span0.32 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsRey-Osterrieth Complex Figure- Copy0.44 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsWAIS-IV Block Design0.39 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsDelis-Kaplan Executive Function-Category Fluency0.39 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsTrail Making Part A0.48 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsRey-Osterrieth Complex Figure- Immediate0.43 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsTrail Making Part B0.49 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsMoCA0.53 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsGeriatric Depression Scale-0.11 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsRey-Osterrieth Complex Figure- Delayed0.39 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsSymbol Digit Modalities0.51 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsDelis-Kaplan Executive Function-Category Switching0.30 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsHamilton-Veale Contrast Sensitivity - Left0.12 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsRey-Osterrieth Complex Figure- Immediate Retention0.22 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsHamilton-Veale Contrast Sensitivity- Right0.09 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsDelis-Kaplan Executive Function- Letter Fluency0.36 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsHamilton-Veale Contrast Sensitivity- Binocular0.24 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsRey-Osterrieth Complex Figure- Delayed Retention-0.06 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsPurdue Peg Board- Left hand0.32 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsDelis-Kaplan Executive Function- Switch Accuracy0.26 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsPurdue Peg Board- Right hand0.35 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsRey-Osterrieth Complex Figure- Organization0.29 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsPurdue Peg Board- Bimanual0.36 Correlation Coefficient
Primary Endpoint (Evaluable) PopulationConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsMMSE0.50 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsPurdue Peg Board- Bimanual0.25 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsMMSENA Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsMoCA0.59 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsBenton Judgment of Line Orientation0.36 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsDelis-Kaplan Executive Function- Letter Fluency0.34 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsDelis-Kaplan Executive Function-Category Fluency0.37 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsDelis-Kaplan Executive Function-Category Switching0.38 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsDelis-Kaplan Executive Function- Switch Accuracy0.36 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsRey-Osterrieth Complex Figure- Copy0.43 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsRey-Osterrieth Complex Figure- Immediate0.31 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsRey-Osterrieth Complex Figure- Delayed0.28 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsRey-Osterrieth Complex Figure- Immediate Retention0.08 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsRey-Osterrieth Complex Figure- Delayed Retention0.03 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsRey-Osterrieth Complex Figure- Organization0.25 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsWAIS-IV Digit Span0.48 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsWAIS-IV Block Design0.42 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsTrail Making Part A0.45 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsTrail Making Part B0.51 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsGeriatric Depression Scale-0.04 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsSymbol Digit Modalities0.49 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsHamilton-Veale Contrast Sensitivity - Left0.10 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsHamilton-Veale Contrast Sensitivity- Right0.17 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsHamilton-Veale Contrast Sensitivity- Binocular0.21 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsPurdue Peg Board- Left hand0.16 Correlation Coefficient
MMSEConstruct Validity of DCTclock as Measured by the Comparison of DCTclock Results to the Results of a Battery of Neuropsychological AssessmentsPurdue Peg Board- Right hand0.22 Correlation Coefficient
Other Pre-specified

Incidence of Serious Device-related Adverse Events [Safety]

Incidence of serious device-related adverse events.

Time frame: Visit 1 and visit 2, occuring 1-4 weeks apart

Population: All qualified participants who completed at least one DCTclock test.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Primary Endpoint (Evaluable) PopulationIncidence of Serious Device-related Adverse Events [Safety]0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026